Roche Lands Breakthrough Designation for Alzheimer’s Test
The Basel, Switzerland-based company’s test looks for the presence of amyloid pathology in patients suspected of having Alzheimer’s.
The Basel, Switzerland-based company’s test looks for the presence of amyloid pathology in patients suspected of having Alzheimer’s.
This week in Pedersen's POV, our senior editor pushes for patient access to breakthrough medical devices.
In this Q&A, MD+DI investigates the connection between how better collaboration among academic institutions and industry could improve the production of medical devices.
Bethany Corbin, a recognized thought leader in women's health, is set to keynote IME South. The six-in-one advanced design and manufacturing expo returns June 4-6 to the Charlotte Convention Center.